DelphX Announces Non-Brokered Unit Private Placement and Warrant Extension
DelphX (OTCQB: DPXCF) announced a non-brokered private placement of 2,800,000 units at C$0.04 per unit for gross proceeds of C$112,000.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
DelphX (OTCQB: DPXCF) announced a non-brokered private placement of 2,800,000 units at C$0.04 per unit for gross proceeds of C$112,000. Each unit includes one common share and one warrant exercisable at $0.07 for two years. Closing is subject to TSX Venture Exchange approval and a four-month-and-one-day hold period on securities. Net proceeds are intended for general corporate purposes.
DelphX also seeks TSXV approval to extend the exercise period of 5,422,221 warrants (exercise price $0.15) by one year to December 7, 2026. 1,611,111 of those warrants are held by related parties; the company says available exemptions under MI 61-101 apply.
Positive
- Gross proceeds of C$112,000 from the unit offering
- 2,800,000 units issued at C$0.04 per unit
- Warrant exercise period extended to Dec 7, 2026 if approved
Negative
- Potential dilution from 2,800,000 new common shares
- 5,422,221 warrants exercisable at $0.15 increase dilution risk
- 1,611,111 warrants held by related parties (related-party transaction)
Details
News Market Reaction – DPXCF
The recorded move for DPXCF in the trading session of this news was +8.14%.
Data tracked by StockTitan Argus. Session date unavailable.
Key Figures
- Units offered
- 2,800,000 units
- New non-brokered private placement
- Unit price
- C$0.04 per Unit
- Subscription price for current offering
- Gross proceeds
- C$112,000
- Expected from current private placement
- Warrant exercise price
- $0.07 per share
- Warrants in new Units, two-year term
- Warrants for extension
- 5,422,221 warrants
- Existing share purchase warrants subject to extension
- Extension exercise price
- $0.15 per share
- Exercise price of warrants to be extended
- Related party warrants
- 1,611,111 warrants
- Held by related parties under MI 61-101
- New expiry date
- December 7, 2026
- Proposed new expiry for extended warrants
Historical Context
-
Closed small non-brokered unit financing for general corporate purposes.
-
Announced intention to raise funds via non-brokered unit offering.
-
Sought TSXV approval to extend expiry of existing warrants by one year.
-
Proposed extensions of two warrant series, including related party holdings.
-
Outlined revenue verticals, new crypto product, and private placement strategy.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
non-brokered private placement financial
hold period financial
Multilateral Instrument 61-101 regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
Toronto, Ontario--(Newsfile Corp. - November 27, 2025) - DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) ("DelphX"), a leader in the development of new classes of structured products, announces that it intends to proceed with a non-brokered private placement ("the Offering") of 2,800,000 units (the "Units") at a subscription price of C
Completion of the Offering is subject to the approval of the TSX Venture Exchange. The securities issued pursuant to the Offering will be subject to a hold period of four months plus one day from the date of issuance.
DelphX intends to use the net proceeds from the Offering in connection with general corporate purposes.
In addition, DelphX announces that it intends to seek approval of the TSX Venture Exchange to extend the exercise period of 5,422,221 share purchase warrants, exercisable at
A total of 1,611,111 warrants are held by parties who are considered to be "related parties" of DelphX Therefore, the amendment of Warrants constitutes a "related party transaction" as contemplated by Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions, and TSXV Policy 5.9 - Protection of Minority Security Holders in Special Transactions. However, the exemptions from formal valuation and minority approval requirements provided for can be relied upon as the fair market value of the Warrants does not exceed
About DelphX Capital Markets Inc.
DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables broker dealers to offer new private placement securities that provide for both fixed income and cryptocurrency solutions. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:
- Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds and/or protection from losses in cryptocurrency holdings;
- Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade and/or cryptocurrency loss exposure of an underlying security or cryptocurrency in exchange for attractive returns.
All CPOs and CRNs are fully collateralized and held in custody by US Bank. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.
For more information about DelphX, please visit www.delphx.com.
George Wentworth, General Manager
DelphX Capital Markets Inc.
george.wentworth@delphx.com
(718) 509-2160
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276177
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.